United States Direct Thrombin Inhibitor Market Report 2017

August 2017 | 113 pages | ID: U1575052AA7EN
QYResearch

Abstracts

In this report, the United States Direct Thrombin Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Direct Thrombin Inhibitor in these regions, from 2012 to 2022 (forecast).

United States Direct Thrombin Inhibitor market competition by top manufacturers/players, with Direct Thrombin Inhibitor sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi
• Bristol-Myers Squibb
• Bayer
• Johnson & Johnson
• Genentech (Roche)
• Boehringer Ingelheim
• Lilly
• Daiichi Sankyo
• Otsuka
• AstraZeneca
• Pfizer
• Aspen

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Oral
• Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Direct Thrombin Inhibitor for each application, including

• VTE
• ACS/MI
• AF
• Others

Contents

United States Direct Thrombin Inhibitor Market Report 2017

1 DIRECT THROMBIN INHIBITOR OVERVIEW

1.1 Product Overview and Scope of Direct Thrombin Inhibitor
1.2 Classification of Direct Thrombin Inhibitor by Product Category
  1.2.1 United States Direct Thrombin Inhibitor Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Direct Thrombin Inhibitor Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Oral
  1.2.4 Injection
1.3 United States Direct Thrombin Inhibitor Market by Application/End Users
  1.3.1 United States Direct Thrombin Inhibitor Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 VTE
  1.3.3 ACS/MI
  1.3.4 AF
  1.3.5 Others
1.4 United States Direct Thrombin Inhibitor Market by Region
  1.4.1 United States Direct Thrombin Inhibitor Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Direct Thrombin Inhibitor Status and Prospect (2012-2022)
  1.4.3 Southwest Direct Thrombin Inhibitor Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Direct Thrombin Inhibitor Status and Prospect (2012-2022)
  1.4.5 New England Direct Thrombin Inhibitor Status and Prospect (2012-2022)
  1.4.6 The South Direct Thrombin Inhibitor Status and Prospect (2012-2022)
  1.4.7 The Midwest Direct Thrombin Inhibitor Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Direct Thrombin Inhibitor (2012-2022)
  1.5.1 United States Direct Thrombin Inhibitor Sales and Growth Rate (2012-2022)
  1.5.2 United States Direct Thrombin Inhibitor Revenue and Growth Rate (2012-2022)

2 UNITED STATES DIRECT THROMBIN INHIBITOR MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Direct Thrombin Inhibitor Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Direct Thrombin Inhibitor Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Direct Thrombin Inhibitor Average Price by Players/Suppliers (2012-2017)
2.4 United States Direct Thrombin Inhibitor Market Competitive Situation and Trends
  2.4.1 United States Direct Thrombin Inhibitor Market Concentration Rate
  2.4.2 United States Direct Thrombin Inhibitor Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Direct Thrombin Inhibitor Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES DIRECT THROMBIN INHIBITOR SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Direct Thrombin Inhibitor Sales and Market Share by Region (2012-2017)
3.2 United States Direct Thrombin Inhibitor Revenue and Market Share by Region (2012-2017)
3.3 United States Direct Thrombin Inhibitor Price by Region (2012-2017)

4 UNITED STATES DIRECT THROMBIN INHIBITOR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Direct Thrombin Inhibitor Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Direct Thrombin Inhibitor Revenue and Market Share by Type (2012-2017)
4.3 United States Direct Thrombin Inhibitor Price by Type (2012-2017)
4.4 United States Direct Thrombin Inhibitor Sales Growth Rate by Type (2012-2017)

5 UNITED STATES DIRECT THROMBIN INHIBITOR SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Direct Thrombin Inhibitor Sales and Market Share by Application (2012-2017)
5.2 United States Direct Thrombin Inhibitor Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES DIRECT THROMBIN INHIBITOR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sanofi
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Direct Thrombin Inhibitor Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi Direct Thrombin Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb
  6.2.2 Direct Thrombin Inhibitor Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bristol-Myers Squibb Direct Thrombin Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bayer
  6.3.2 Direct Thrombin Inhibitor Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bayer Direct Thrombin Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson
  6.4.2 Direct Thrombin Inhibitor Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Johnson & Johnson Direct Thrombin Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Genentech (Roche)
  6.5.2 Direct Thrombin Inhibitor Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Genentech (Roche) Direct Thrombin Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Boehringer Ingelheim
  6.6.2 Direct Thrombin Inhibitor Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Boehringer Ingelheim Direct Thrombin Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Lilly
  6.7.2 Direct Thrombin Inhibitor Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Lilly Direct Thrombin Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Daiichi Sankyo
  6.8.2 Direct Thrombin Inhibitor Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Daiichi Sankyo Direct Thrombin Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Otsuka
  6.9.2 Direct Thrombin Inhibitor Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Otsuka Direct Thrombin Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 AstraZeneca
  6.10.2 Direct Thrombin Inhibitor Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 AstraZeneca Direct Thrombin Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Pfizer
6.12 Aspen

7 DIRECT THROMBIN INHIBITOR MANUFACTURING COST ANALYSIS

7.1 Direct Thrombin Inhibitor Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Direct Thrombin Inhibitor

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Direct Thrombin Inhibitor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Direct Thrombin Inhibitor Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DIRECT THROMBIN INHIBITOR MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Direct Thrombin Inhibitor Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Direct Thrombin Inhibitor Sales Volume Forecast by Type (2017-2022)
11.3 United States Direct Thrombin Inhibitor Sales Volume Forecast by Application (2017-2022)
11.4 United States Direct Thrombin Inhibitor Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Direct Thrombin Inhibitor
Figure United States Direct Thrombin Inhibitor Market Size (K Units) by Type (2012-2022)
Figure United States Direct Thrombin Inhibitor Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Product Picture
Figure Injection Product Picture
Figure United States Direct Thrombin Inhibitor Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Direct Thrombin Inhibitor by Application in 2016
Figure VTE Examples
Figure ACS/MI Examples
Figure AF Examples
Figure Others Examples
Figure United States Direct Thrombin Inhibitor Market Size (Million USD) by Region (2012-2022)
Figure The West Direct Thrombin Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Direct Thrombin Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Direct Thrombin Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Direct Thrombin Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Direct Thrombin Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Direct Thrombin Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Direct Thrombin Inhibitor Sales (K Units) and Growth Rate (2012-2022)
Figure United States Direct Thrombin Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Direct Thrombin Inhibitor Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Direct Thrombin Inhibitor Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Direct Thrombin Inhibitor Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Direct Thrombin Inhibitor Sales Share by Players/Suppliers
Figure 2017 United States Direct Thrombin Inhibitor Sales Share by Players/Suppliers
Figure United States Direct Thrombin Inhibitor Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Direct Thrombin Inhibitor Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Direct Thrombin Inhibitor Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Direct Thrombin Inhibitor Revenue Share by Players/Suppliers
Figure 2017 United States Direct Thrombin Inhibitor Revenue Share by Players/Suppliers
Table United States Market Direct Thrombin Inhibitor Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Direct Thrombin Inhibitor Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Direct Thrombin Inhibitor Market Share of Top 3 Players/Suppliers
Figure United States Direct Thrombin Inhibitor Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Direct Thrombin Inhibitor Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Direct Thrombin Inhibitor Product Category
Table United States Direct Thrombin Inhibitor Sales (K Units) by Region (2012-2017)
Table United States Direct Thrombin Inhibitor Sales Share by Region (2012-2017)
Figure United States Direct Thrombin Inhibitor Sales Share by Region (2012-2017)
Figure United States Direct Thrombin Inhibitor Sales Market Share by Region in 2016
Table United States Direct Thrombin Inhibitor Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Direct Thrombin Inhibitor Revenue Share by Region (2012-2017)
Figure United States Direct Thrombin Inhibitor Revenue Market Share by Region (2012-2017)
Figure United States Direct Thrombin Inhibitor Revenue Market Share by Region in 2016
Table United States Direct Thrombin Inhibitor Price (USD/Unit) by Region (2012-2017)
Table United States Direct Thrombin Inhibitor Sales (K Units) by Type (2012-2017)
Table United States Direct Thrombin Inhibitor Sales Share by Type (2012-2017)
Figure United States Direct Thrombin Inhibitor Sales Share by Type (2012-2017)
Figure United States Direct Thrombin Inhibitor Sales Market Share by Type in 2016
Table United States Direct Thrombin Inhibitor Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Direct Thrombin Inhibitor Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Direct Thrombin Inhibitor by Type (2012-2017)
Figure Revenue Market Share of Direct Thrombin Inhibitor by Type in 2016
Table United States Direct Thrombin Inhibitor Price (USD/Unit) by Types (2012-2017)
Figure United States Direct Thrombin Inhibitor Sales Growth Rate by Type (2012-2017)
Table United States Direct Thrombin Inhibitor Sales (K Units) by Application (2012-2017)
Table United States Direct Thrombin Inhibitor Sales Market Share by Application (2012-2017)
Figure United States Direct Thrombin Inhibitor Sales Market Share by Application (2012-2017)
Figure United States Direct Thrombin Inhibitor Sales Market Share by Application in 2016
Table United States Direct Thrombin Inhibitor Sales Growth Rate by Application (2012-2017)
Figure United States Direct Thrombin Inhibitor Sales Growth Rate by Application (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Direct Thrombin Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Direct Thrombin Inhibitor Sales Growth Rate (2012-2017)
Figure Sanofi Direct Thrombin Inhibitor Sales Market Share in United States (2012-2017)
Figure Sanofi Direct Thrombin Inhibitor Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Direct Thrombin Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Direct Thrombin Inhibitor Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Direct Thrombin Inhibitor Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Direct Thrombin Inhibitor Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Direct Thrombin Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Direct Thrombin Inhibitor Sales Growth Rate (2012-2017)
Figure Bayer Direct Thrombin Inhibitor Sales Market Share in United States (2012-2017)
Figure Bayer Direct Thrombin Inhibitor Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Direct Thrombin Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Direct Thrombin Inhibitor Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Direct Thrombin Inhibitor Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Direct Thrombin Inhibitor Revenue Market Share in United States (2012-2017)
Table Genentech (Roche) Basic Information List
Table Genentech (Roche) Direct Thrombin Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genentech (Roche) Direct Thrombin Inhibitor Sales Growth Rate (2012-2017)
Figure Genentech (Roche) Direct Thrombin Inhibitor Sales Market Share in United States (2012-2017)
Figure Genentech (Roche) Direct Thrombin Inhibitor Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Direct Thrombin Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Direct Thrombin Inhibitor Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Direct Thrombin Inhibitor Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Direct Thrombin Inhibitor Revenue Market Share in United States (2012-2017)
Table Lilly Basic Information List
Table Lilly Direct Thrombin Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lilly Direct Thrombin Inhibitor Sales Growth Rate (2012-2017)
Figure Lilly Direct Thrombin Inhibitor Sales Market Share in United States (2012-2017)
Figure Lilly Direct Thrombin Inhibitor Revenue Market Share in United States (2012-2017)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Direct Thrombin Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Daiichi Sankyo Direct Thrombin Inhibitor Sales Growth Rate (2012-2017)
Figure Daiichi Sankyo Direct Thrombin Inhibitor Sales Market Share in United States (2012-2017)
Figure Daiichi Sankyo Direct Thrombin Inhibitor Revenue Market Share in United States (2012-2017)
Table Otsuka Basic Information List
Table Otsuka Direct Thrombin Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Otsuka Direct Thrombin Inhibitor Sales Growth Rate (2012-2017)
Figure Otsuka Direct Thrombin Inhibitor Sales Market Share in United States (2012-2017)
Figure Otsuka Direct Thrombin Inhibitor Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Direct Thrombin Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Direct Thrombin Inhibitor Sales Growth Rate (2012-2017)
Figure AstraZeneca Direct Thrombin Inhibitor Sales Market Share in United States (2012-2017)
Figure AstraZeneca Direct Thrombin Inhibitor Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Aspen Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Direct Thrombin Inhibitor
Figure Manufacturing Process Analysis of Direct Thrombin Inhibitor
Figure Direct Thrombin Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of Direct Thrombin Inhibitor Major Players/Suppliers in 2016
Table Major Buyers of Direct Thrombin Inhibitor
Table Distributors/Traders List
Figure United States Direct Thrombin Inhibitor Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Direct Thrombin Inhibitor Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Direct Thrombin Inhibitor Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Direct Thrombin Inhibitor Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Direct Thrombin Inhibitor Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Direct Thrombin Inhibitor Sales Volume (K Units) Forecast by Type in 2022
Table United States Direct Thrombin Inhibitor Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Direct Thrombin Inhibitor Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Direct Thrombin Inhibitor Sales Volume (K Units) Forecast by Application in 2022
Table United States Direct Thrombin Inhibitor Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Direct Thrombin Inhibitor Sales Volume Share Forecast by Region (2017-2022)
Figure United States Direct Thrombin Inhibitor Sales Volume Share Forecast by Region (2017-2022)
Figure United States Direct Thrombin Inhibitor Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources